David Shapiro - CEO of B2i Digital
@b2idigital.bsky.social
B2i Digital executes targeted digital marketing campaigns to generate investor awareness for public companies. David Shapiro is the Founder & CEO. b2idigital.com
Pinned
BNB Plus Corp. (Nasdaq: BNBX) announced the successful manufacture and shipment of its largest single LineaDNA order in company history, valued at over $390,000.
BNB Plus (Nasdaq: BNBX) is a B2i Digital Featured Company. See the comprehensive profile at b2idigital.com/bnbx.
BNB Plus (Nasdaq: BNBX) is a B2i Digital Featured Company. See the comprehensive profile at b2idigital.com/bnbx.
Kolibri Global Energy (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference. In a brief video clip, he describes the company’s acreage history and the evolution of the Tishomingo Field into a predominantly oil-weighted asset
December 29, 2025 at 7:47 PM
Kolibri Global Energy (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference. In a brief video clip, he describes the company’s acreage history and the evolution of the Tishomingo Field into a predominantly oil-weighted asset
Unicycive Therapeutics (Nasdaq: UNCY) resubmitted its 505(b)(2) NDA to the FDA for oxylanthanum carbonate (OLC), a phosphate binder for dialysis patients with hyperphosphatemia. A new PDUFA date is expected in 1H 2026.
View their comprehensive profile at b2idigital.com/unicycive.
View their comprehensive profile at b2idigital.com/unicycive.
December 29, 2025 at 7:19 PM
Unicycive Therapeutics (Nasdaq: UNCY) resubmitted its 505(b)(2) NDA to the FDA for oxylanthanum carbonate (OLC), a phosphate binder for dialysis patients with hyperphosphatemia. A new PDUFA date is expected in 1H 2026.
View their comprehensive profile at b2idigital.com/unicycive.
View their comprehensive profile at b2idigital.com/unicycive.
Applied Energetics, Inc. (OTCQB: AERG), announced its selection to participate in the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle.
December 29, 2025 at 4:06 PM
Applied Energetics, Inc. (OTCQB: AERG), announced its selection to participate in the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle.
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) recently announced an operations update on its Tishomingo field in Oklahoma, reporting field-wide production of over 6,000 barrels of oil equivalent per day with the addition of newly completed Barnes and Velin wells.
December 22, 2025 at 9:18 PM
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) recently announced an operations update on its Tishomingo field in Oklahoma, reporting field-wide production of over 6,000 barrels of oil equivalent per day with the addition of newly completed Barnes and Velin wells.
Vision changes after a stroke can develop gradually and may go unnoticed during recovery. Vycor’s NovaVision division offers a free online visual field screening tool that helps patients identify potential concerns and support informed conversations with healthcare providers.
December 22, 2025 at 6:35 PM
Vision changes after a stroke can develop gradually and may go unnoticed during recovery. Vycor’s NovaVision division offers a free online visual field screening tool that helps patients identify potential concerns and support informed conversations with healthcare providers.
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference.
December 22, 2025 at 6:23 PM
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference.
BNB Plus Corp. (Nasdaq: BNBX) announced the successful manufacture and shipment of its largest single LineaDNA order in company history, valued at over $390,000.
BNB Plus (Nasdaq: BNBX) is a B2i Digital Featured Company. See the comprehensive profile at b2idigital.com/bnbx.
BNB Plus (Nasdaq: BNBX) is a B2i Digital Featured Company. See the comprehensive profile at b2idigital.com/bnbx.
December 18, 2025 at 6:03 PM
BNB Plus Corp. (Nasdaq: BNBX) announced the successful manufacture and shipment of its largest single LineaDNA order in company history, valued at over $390,000.
BNB Plus (Nasdaq: BNBX) is a B2i Digital Featured Company. See the comprehensive profile at b2idigital.com/bnbx.
BNB Plus (Nasdaq: BNBX) is a B2i Digital Featured Company. See the comprehensive profile at b2idigital.com/bnbx.
In a recent International Business Times article, eXoZymes (Nasdaq: EXOZ) addressed one of biotech’s persistent frustrations: why promising molecules discovered in the lab so rarely make it to commercial scale.
December 17, 2025 at 6:59 PM
In a recent International Business Times article, eXoZymes (Nasdaq: EXOZ) addressed one of biotech’s persistent frustrations: why promising molecules discovered in the lab so rarely make it to commercial scale.
Many stroke survivors are unaware that structured vision rehabilitation programs combine multiple therapeutic approaches to support recovery. One of these approaches is NeuroEyeCoach, provided by Vycor’s NovaVision division.
December 17, 2025 at 6:51 PM
Many stroke survivors are unaware that structured vision rehabilitation programs combine multiple therapeutic approaches to support recovery. One of these approaches is NeuroEyeCoach, provided by Vycor’s NovaVision division.
Applied Energetics (OTCQB: AERG) announced the successful completion of its first outdoor test of its next-generation ultrashort pulse laser subsystem, marking a key transition from laboratory testing to real-world operational environments.
View its profile at b2idigital.com/applied-ener....
View its profile at b2idigital.com/applied-ener....
December 16, 2025 at 6:15 PM
Applied Energetics (OTCQB: AERG) announced the successful completion of its first outdoor test of its next-generation ultrashort pulse laser subsystem, marking a key transition from laboratory testing to real-world operational environments.
View its profile at b2idigital.com/applied-ener....
View its profile at b2idigital.com/applied-ener....
Kolibri Global Energy (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference. In a brief video clip, he outlines the company’s financial approach and its fully funded 2025 drilling program in Oklahoma.
December 15, 2025 at 7:04 PM
Kolibri Global Energy (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference. In a brief video clip, he outlines the company’s financial approach and its fully funded 2025 drilling program in Oklahoma.
OS Therapies Inc. (NYSE American: OSTX) announced a successful Type C meeting with the US Food & Drug Administration regarding its Phase 2b clinical trial of OST-HER2 in the prevention or delay of recurrent, fully resected, pulmonary metastatic osteosarcoma.
View their profile at lnkd.in/epFNRZQB.
View their profile at lnkd.in/epFNRZQB.
December 15, 2025 at 1:31 PM
OS Therapies Inc. (NYSE American: OSTX) announced a successful Type C meeting with the US Food & Drug Administration regarding its Phase 2b clinical trial of OST-HER2 in the prevention or delay of recurrent, fully resected, pulmonary metastatic osteosarcoma.
View their profile at lnkd.in/epFNRZQB.
View their profile at lnkd.in/epFNRZQB.
eXoZymes (Nasdaq: EXOZ) announced the achievement of a 100-fold scale-up of its N-trans-caffeoyltyramine (NCT) production process, demonstrating over 99% conversion from feedstock to product using its proprietary exozyme-based, cell-free biomanufacturing platform.
December 12, 2025 at 7:34 PM
eXoZymes (Nasdaq: EXOZ) announced the achievement of a 100-fold scale-up of its N-trans-caffeoyltyramine (NCT) production process, demonstrating over 99% conversion from feedstock to product using its proprietary exozyme-based, cell-free biomanufacturing platform.
BNB Plus Corp. (Nasdaq: BNBX) Chief Investment Officer Patrick Horsman highlighted a key advantage of BNB as a productive asset during the Odyssey podcast, explaining how the Digital Asset Treasury can continue generating yields and accumulating tokens even during market downturns.
December 12, 2025 at 5:31 PM
BNB Plus Corp. (Nasdaq: BNBX) Chief Investment Officer Patrick Horsman highlighted a key advantage of BNB as a productive asset during the Odyssey podcast, explaining how the Digital Asset Treasury can continue generating yields and accumulating tokens even during market downturns.
Xtant Medical Holdings (NYSE-American: XTNT) announced the commercial launch of nanOss Strata™, its next-generation synthetic bone graft designed to more closely mimic human bone structure, increase surface area, and enhance cellular activity for better integration and remodeling during healing.
December 11, 2025 at 6:59 PM
Xtant Medical Holdings (NYSE-American: XTNT) announced the commercial launch of nanOss Strata™, its next-generation synthetic bone graft designed to more closely mimic human bone structure, increase surface area, and enhance cellular activity for better integration and remodeling during healing.
BNB Plus Corp. (Nasdaq: BNBX) Chief Investment Officer Patrick Horsman recently discussed the company’s focused investment mandate during an appearance on the Odyssey podcast, explaining how the Digital Asset Treasury maintains its disciplined approach to BNB accumulation.
December 10, 2025 at 9:14 PM
BNB Plus Corp. (Nasdaq: BNBX) Chief Investment Officer Patrick Horsman recently discussed the company’s focused investment mandate during an appearance on the Odyssey podcast, explaining how the Digital Asset Treasury maintains its disciplined approach to BNB accumulation.
The team at B2i Digital is pleased to highlight the upcoming Life Sciences Virtual Investor Forum taking place on December 11, 2025.
Register:
lnkd.in/er2WjPAg
Register:
lnkd.in/er2WjPAg
December 10, 2025 at 3:20 PM
The team at B2i Digital is pleased to highlight the upcoming Life Sciences Virtual Investor Forum taking place on December 11, 2025.
Register:
lnkd.in/er2WjPAg
Register:
lnkd.in/er2WjPAg
BNB Plus Corp. (Nasdaq: BNBX) announced strategic treasury growth with the acquisition of 3,349 additional BNB tokens, operational improvements at its LineaRx subsidiary, and the launch of its new corporate website and branding.
December 9, 2025 at 9:06 PM
BNB Plus Corp. (Nasdaq: BNBX) announced strategic treasury growth with the acquisition of 3,349 additional BNB tokens, operational improvements at its LineaRx subsidiary, and the launch of its new corporate website and branding.
BNB Plus Corp. (Nasdaq: BNBX) recently joined the Odyssey podcast for a wide-ranging discussion about its Digital Asset Treasury model, why the team selected BNB as a productive treasury asset, and how yield strategies are designed to increase long-term token holdings for shareholders.
December 9, 2025 at 5:07 PM
BNB Plus Corp. (Nasdaq: BNBX) recently joined the Odyssey podcast for a wide-ranging discussion about its Digital Asset Treasury model, why the team selected BNB as a productive treasury asset, and how yield strategies are designed to increase long-term token holdings for shareholders.
OS Therapies (NYSE American: OSTX) announced a successful pre-Marketing Authorisation Application (MAA) meeting with the UK Medicines and Healthcare Products Regulatory Agency (MHRA) regarding its Phase 2b clinical trial of OST-HER2
December 9, 2025 at 4:54 PM
OS Therapies (NYSE American: OSTX) announced a successful pre-Marketing Authorisation Application (MAA) meeting with the UK Medicines and Healthcare Products Regulatory Agency (MHRA) regarding its Phase 2b clinical trial of OST-HER2
Many stroke survivors are unaware that structured vision rehabilitation programs combine multiple therapeutic approaches to support recovery. Vycor’s NovaVision division offers two complementary therapies that work together to help patients navigate the challenges of post-stroke vision changes.
December 9, 2025 at 4:46 PM
Many stroke survivors are unaware that structured vision rehabilitation programs combine multiple therapeutic approaches to support recovery. Vycor’s NovaVision division offers two complementary therapies that work together to help patients navigate the challenges of post-stroke vision changes.
B2i Digital is proud to be named the Official Marketing Partner for Virtual Investor Conferences (VIC), the long-running online investor event series owned and operated by OTC Markets Group Inc.
December 9, 2025 at 2:16 AM
B2i Digital is proud to be named the Official Marketing Partner for Virtual Investor Conferences (VIC), the long-running online investor event series owned and operated by OTC Markets Group Inc.
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference. In a brief video clip, he shares operational updates on the company’s Caney drilling program in Oklahoma.
December 8, 2025 at 5:22 PM
Kolibri Global Energy Inc. (Nasdaq: KGEI, TSX: KEI) President & CEO Wolf Regener recently presented at the OTC Markets Oil & Gas Virtual Investor Conference. In a brief video clip, he shares operational updates on the company’s Caney drilling program in Oklahoma.
OS Therapies (NYSE American: OSTX) announced that the U.S. Food & Drug Administration has granted a waiver of the application fee for BLA 125867 for OST-HER2.
December 5, 2025 at 4:51 PM
OS Therapies (NYSE American: OSTX) announced that the U.S. Food & Drug Administration has granted a waiver of the application fee for BLA 125867 for OST-HER2.
B2i Digital is pleased to announce Curiosity Inc. is participating in the 14th Annual ROTH Deer Valley Event hosted by ROTH Capital Partners taking place December 10–13, 2025, at the Montage Deer Valley in Park City, Utah.
December 4, 2025 at 8:30 PM
B2i Digital is pleased to announce Curiosity Inc. is participating in the 14th Annual ROTH Deer Valley Event hosted by ROTH Capital Partners taking place December 10–13, 2025, at the Montage Deer Valley in Park City, Utah.